Martin Huber
Corporate Officer/Principal chez NAUTILUS BIOTECHNOLOGY, INC.
Postes actifs de Martin Huber
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NAUTILUS BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 01/11/2023 | - |
Historique de carrière de Martin Huber
Anciens postes connus de Martin Huber
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Quantapore, Inc.
 Quantapore, Inc. BiotechnologyHealth Technology Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA. | Directeur/Membre du Conseil | 01/01/2009 | - |
| Directeur Général | 01/01/2009 | - | |
| Fondateur | 01/01/2009 | - |
Formation de Martin Huber
| University of Vienna | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Autriche | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NAUTILUS BIOTECHNOLOGY, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Quantapore, Inc.
Quantapore, Inc. BiotechnologyHealth Technology Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA. | Health Technology |
- Bourse
- Insiders
- Martin Huber
- Expérience
